Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Haleos Labs Ltd

NSE: HALEOSLABS · BSE: 540679 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹1,584.00
Market cap
₹478.9 Cr
Revenue (annual)
₹333.8 Cr
Net profit (annual)
₹17.31 Cr
P/E (TTM)
30.3×Sector 47.4×
Promoter holding
72.11%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:58 IST BSE
Other Announcement

Haleos Labs Other Announcement

Haleos Labs Ltd notified shareholders of the Annual Report and AGM notice weblink, while requesting updates to their KYC and email addresses.

18:27 IST BSE
Other Announcement

Haleos Labs Other Announcement

Haleos Labs is transferring shares to the IEPF suspense account for unclaimed dividends from FY 2018-19. This is a routine regulatory compliance with no material financial impact.

13:36 IST BSE
Other Announcement

Haleos Labs Other Announcement

Haleos Labs Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no new fines.

13:30 IST BSE
Other Announcement

Haleos Labs Other Announcement

Haleos Labs Ltd submitted its quarterly RTA compliance certificate for the period ended March 31, 2026. The certificate confirms compliance with SEBI dematerialisation regulations, including the cancellation of physical security certificates. This is a routine regulatory disclosure with no immediate financial impact.